Related Experiment Videos
[Desmopressin: the treatment of primary nocturnal enuresis]
1Unidad de Urología Pediátrica, Fundación Puigvert, Barcelona, España.
Archivos Espanoles De Urologia
|April 1, 1995
Abstract
Objectives:
The efficacy of desmopressin, a drug that reduces nocturnal urine volume with no side effects, was evaluated in a group of 21 patients.
Methods:
20 boys and 1 girl with primary nocturnal enuresis were treated with intranasal desmopressin (DDAVP) for a period of 12 weeks.
Results:
An improvement in 80.95% was achieved. Following treatment enuresis recurred, but to a lesser degree than before therapy.
Conclusions:
DDAVP is useful in the treatment of primary nocturnal enuresis whose etiology is not organic or functional.